Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | protease, serine, 1 (trypsin 1) | Starlite/ChEMBL | References |
Homo sapiens | coagulation factor X | Starlite/ChEMBL | References |
Homo sapiens | coagulation factor II (thrombin) | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Trypsin family protein | protease, serine, 1 (trypsin 1) | 247 aa | 287 aa | 21.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Protein-tyrosine phosphatase containing protein | 0.036 | 0.6701 | 0.8989 |
Echinococcus multilocularis | tyrosine protein phosphatase non receptor type | 0.036 | 0.6701 | 0.669 |
Entamoeba histolytica | protein kinase, putative | 0.0067 | 0.0033 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0067 | 0.0033 | 1 |
Loa Loa (eye worm) | protein-tyrosine phosphatase | 0.036 | 0.6701 | 0.7491 |
Entamoeba histolytica | protein kinase, putative | 0.0067 | 0.0033 | 0.5 |
Trypanosoma brucei | rac serine-threonine kinase, putative | 0.0067 | 0.0033 | 0.5 |
Brugia malayi | ribosomal protein S6 kinase alpha 3 | 0.0393 | 0.7451 | 1 |
Loa Loa (eye worm) | AGC/RSK/RSK protein kinase | 0.0458 | 0.8935 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0067 | 0.0033 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0067 | 0.0033 | 1 |
Echinococcus granulosus | receptor type tyrosine protein phosphatase | 0.0505 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.1239 | 0.1355 |
Trichomonas vaginalis | AGC family protein kinase | 0.0067 | 0.0033 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0458 | 0.8935 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.1239 | 0.1355 |
Echinococcus multilocularis | ribosomal protein S6 kinase alpha 3 | 0.0458 | 0.8935 | 0.8932 |
Trichomonas vaginalis | AGC family protein kinase | 0.0067 | 0.0033 | 1 |
Echinococcus multilocularis | receptor type tyrosine protein phosphatase protein tyrosine phosphatase receptor type | 0.0505 | 1 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0067 | 0.0033 | 0.5 |
Onchocerca volvulus | 0.012 | 0.1239 | 1 | |
Echinococcus granulosus | tyrosine protein phosphatase non receptor type | 0.036 | 0.6701 | 0.669 |
Trichomonas vaginalis | AGC family protein kinase | 0.0067 | 0.0033 | 1 |
Schistosoma mansoni | protein tyrosine phosphatase non-receptor type nt1 | 0.036 | 0.6701 | 0.7491 |
Toxoplasma gondii | AGC kinase | 0.0067 | 0.0033 | 0.5 |
Leishmania major | rac serine-threonine kinase, putative,protein kinase, putative | 0.0393 | 0.7451 | 0.5 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.012 | 0.1239 | 0.1355 |
Giardia lamblia | Kinase, AGC AKT | 0.0393 | 0.7451 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0067 | 0.0033 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0067 | 0.0033 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0067 | 0.0033 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0067 | 0.0033 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0067 | 0.0033 | 1 |
Echinococcus granulosus | ribosomal protein S6 kinase alpha 3 | 0.0458 | 0.8935 | 0.8932 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.012 | 0.1239 | 0.1355 |
Brugia malayi | Trypsin family protein | 0.012 | 0.1239 | 0.1626 |
Trichomonas vaginalis | AGC family protein kinase | 0.0067 | 0.0033 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AUC (ADMET) | = 9.9 ug min ml-1 | In vivo area under curve was calculated by peroral administration at 1 mg/kg in fasted dog | ChEMBL. | 11934589 |
Cmax (ADMET) | = 0.14 ug ml-1 | In vivo maximal concentration was calculated at 1 mg/kg in dog | ChEMBL. | 11934589 |
Ki (binding) | = 5.3 nM | In vitro inhibitory constant against human thrombin (FIIa). | ChEMBL. | 11934589 |
Ki (binding) | = 5.3 nM | In vitro inhibitory constant against human thrombin (FIIa). | ChEMBL. | 11934589 |
Ki (binding) | = 18.7 nM | In vitro inhibitory constant against trypsin | ChEMBL. | 11934589 |
Ki (binding) | = 18.7 nM | In vitro inhibitory constant against trypsin | ChEMBL. | 11934589 |
Ki (binding) | = 152.7 nM | In vitro inhibitory constant against factor Xa (FXa) was tested | ChEMBL. | 11934589 |
Ki (binding) | = 152.7 nM | In vitro inhibitory constant against factor Xa (FXa) was tested | ChEMBL. | 11934589 |
pKa (binding) | = 10.2 | In vitro potency towards human thrombin (FIIa). | ChEMBL. | 11934589 |
T1/2 (ADMET) | = 53 min | In vivo half life period was calculated at 1 mg/kg in dog | ChEMBL. | 11934589 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.